Express News | Dermata Therapeutics Entered Into ATM Agreement With H.C. Wainwright Providing For Sale By Co Of $1.2M Of Its Shares Of Common Stock From Time To Time

BenzingaJun 7 17:21 ET

Express News | Dermata Therapeutics - Aggregate Market Value of Shares of Common Stock Eligible for Sale Under Atm Prospectus Supplement Is Currently $1.2 Mln

ReutersJun 7 17:15 ET

Express News | Dermata Therapeutics-Entered Into Atm Agreement With H.c. Wainwright Providing for Sale by Co of Its Shares of Common Stock From Time to Time

ReutersJun 7 17:14 ET

Express News | Dermata Therapeutics Inc - on June 4 Got Letter From Nasdaq That Company Has Regained Compliance With Minimum Bid Price Requirement

ReutersJun 5 09:04 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersReshape Lifesciences (NASDAQ:RSLS) shares rose 88.9% to $0.39 during Tuesday's after-market session. The market value of their outstanding shares is at $9.2 million. Dermata Therapeutics (NASDA

BenzingaMay 28 16:31 ET

Acne Vulgaris Market to Register Sustainable Growth by 2034, Examines DelveInsight | Key Companies - Dermata Therapeutics, AstraZeneca, Novartis Pharmaceuticals, UCB Pharma, Incyte Corporation

The dynamics of the acne vulgaris market are anticipated to change in the coming years owing to the increase in the prevalent cases of acne vulgaris, along with the expected launch of emerging therap

PR NewswireMay 27 05:30 ET